Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cervical Cancer
  Free Subscription

Articles published in
BMC Cancer
    April 2024
  1. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
    Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
    BMC Cancer. 2024;24:450.
    >> Share

  2. LI Z, Zhou G, Jiang L, Wang M, et al
    Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
    BMC Cancer. 2024;24:401.
    >> Share

    March 2024
  3. LI X, Zhao Y, Xiang F, Zhang X, et al
    Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
    BMC Cancer. 2024;24:381.
    >> Share

  4. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
    Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
    BMC Cancer. 2024;24:375.
    >> Share

  5. CUI X, Wang H, Chen M, Seery S, et al
    Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
    BMC Cancer. 2024;24:349.
    >> Share

  6. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
    BMC Cancer. 2024;24:351.
    >> Share

  7. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
    Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
    BMC Cancer. 2024;24:308.
    >> Share

  8. ZHANG Y, Liu S, Chen M, Ou Q, et al
    Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
    BMC Cancer. 2024;24:288.
    >> Share

    February 2024
  9. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.
    BMC Cancer. 2024;24:259.
    >> Share

  10. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    >> Share

  11. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
    Using administrative registries as a source for population-based cancer incidence and mortality.
    BMC Cancer. 2024;24:232.
    >> Share

  12. ZHONG ML, Liu YC, Yang JT, Wang YN, et al
    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
    BMC Cancer. 2024;24:217.
    >> Share

  13. XIAO L, Dong X, Sun J, Zhang X, et al
    Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
    BMC Cancer. 2024;24:169.
    >> Share

  14. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
    Sociodemographic characteristics and their association with survival in women with cervical cancer.
    BMC Cancer. 2024;24:161.
    >> Share

    January 2024
  15. LIU H, Cui Y, Chang C, Zhou Z, et al
    Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
    BMC Cancer. 2024;24:150.
    >> Share

  16. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    BMC Cancer. 2024;24:106.
    >> Share

  17. YU JH, Tong CJ, Huang QD, Ye YL, et al
    Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
    BMC Cancer. 2024;24:88.
    >> Share

  18. KAIZILEGE GK, Ndaboine E, Chuma C, Mujuni F, et al
    Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
    BMC Cancer. 2024;24:66.
    >> Share

  19. KUSSIA B, Shewangizaw M, Abebe S, Alemu H, et al
    Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
    BMC Cancer. 2024;24:38.
    >> Share

    December 2023
  20. ZEWDIE A, Shitu S, Kebede N, Gashaw A, et al
    Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1228.
    >> Share

  21. VIGNESHWARAN E, Goruntla N, Bommireddy BR, Mantargi MJS, et al
    Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    BMC Cancer. 2023;23:1216.
    >> Share

  22. KONG L, Xiao X, Xu T, Wan R, et al
    Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
    BMC Cancer. 2023;23:1211.
    >> Share

    November 2023
  23. CHENG Z, Wang H, Yang Z, Li J, et al
    LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/beta-catenin signaling pathway and EMT in cervical cancer.
    BMC Cancer. 2023;23:1128.
    >> Share

  24. ZHANG H, Yang Y, Xing W, Li Y, et al
    Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
    BMC Cancer. 2023;23:1124.
    >> Share

  25. GLINSKA P, Komerska K, Janik B, Olkowicz J, et al
    HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
    BMC Cancer. 2023;23:1118.
    >> Share

  26. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
    Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    BMC Cancer. 2023;23:1104.
    >> Share

  27. BUKOWSKI A, Hoyo C, Vielot NA, Graff M, et al
    Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
    BMC Cancer. 2023;23:1072.
    >> Share

  28. LI X, Wei X, Liu X, Wang N, et al
    The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
    BMC Cancer. 2023;23:1052.
    >> Share

    October 2023
  29. TSEGAYE K, Hagos A, Kindie H, Minyihun A, et al
    Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
    BMC Cancer. 2023;23:1034.
    >> Share

  30. LV N, Zhao Y, Song Y, Ji M, et al
    Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
    BMC Cancer. 2023;23:1022.
    >> Share

  31. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Correction: Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:963.
    >> Share

  32. MISGUN T, Demissie DB
    Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia.
    BMC Cancer. 2023;23:961.
    >> Share

  33. WANG J, Huang J, Ding H, Ma J, et al
    Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    BMC Cancer. 2023;23:929.
    >> Share

    September 2023
  34. SHAN M, Deng Y, Zou W, Fan S, et al
    Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
    BMC Cancer. 2023;23:905.
    >> Share

  35. HE C, Pei C, Ma J
    Developing an evaluation indicators of health literacy for cervical cancer among Chinese women: a modified Delphi method study.
    BMC Cancer. 2023;23:863.
    >> Share

  36. WANG F, Song S, Guo B, Li Y, et al
    Increased TCP11 gene expression can inhibit the proliferation, migration and promote apoptosis of cervical cancer cells.
    BMC Cancer. 2023;23:853.
    >> Share

  37. ZHU M, Li X, Feng Y, Jia T, et al
    Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study.
    BMC Cancer. 2023;23:845.
    >> Share

  38. CHETTY-SEBASTIAN D, Assounga AG
    Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
    BMC Cancer. 2023;23:830.
    >> Share

  39. O'DOWD EL, Merriel SWD, Cheng VWT, Khan S, et al
    Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
    BMC Cancer. 2023;23:820.
    >> Share

  40. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:819.
    >> Share

    August 2023
  41. SAMADI M, Mokhtari-Azad T, Nejati A, Norooz-Babaei Z, et al
    The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
    BMC Cancer. 2023;23:803.
    >> Share

  42. DADIPOOR S, Alavi A, Kader Z, Mohseni S, et al
    Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.
    BMC Cancer. 2023;23:730.
    >> Share

    July 2023
  43. ZHANG C, Gu L, Xiao J, Jin F, et al
    Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    BMC Cancer. 2023;23:684.
    >> Share

  44. MUSA J, Maiga M, Green SJ, Magaji FA, et al
    Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
    BMC Cancer. 2023;23:683.
    >> Share

  45. MARTINEZ-GUTIERREZ J, Chima S, Boyd L, Sherwani A, et al
    Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
    BMC Cancer. 2023;23:653.
    >> Share

  46. NAJJEMBA JI, Ndagire R, Mulamira P, Kibudde S, et al
    Treatment compliance among adult cervical cancer patients receiving care at Uganda cancer institute, Uganda: a retrospective data review.
    BMC Cancer. 2023;23:631.
    >> Share

    June 2023
  47. PENG H, Zhang J, Xu N, Zhou Y, et al
    Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
    BMC Cancer. 2023;23:588.
    >> Share

    May 2023
  48. WU J, Guo Q, Zhu J, Wu Y, et al
    Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
    BMC Cancer. 2023;23:485.
    >> Share

  49. JIANG Y, Wang J, Jiang P, Wang X, et al
    Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
    BMC Cancer. 2023;23:481.
    >> Share

  50. BELAY AS, Asmare WN, Kassie A
    Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model.
    BMC Cancer. 2023;23:472.
    >> Share

  51. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
    Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
    BMC Cancer. 2023;23:466.
    >> Share

  52. MATOVU JK, Wagner GJ, Juncker M, Namisango E, et al
    Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
    BMC Cancer. 2023;23:428.
    >> Share

  53. YE Y, Li Z, Kang S, Yang Y, et al
    Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
    BMC Cancer. 2023;23:421.
    >> Share

  54. BOOTH BB, Tranberg M, Gustafson LW, Christiansen AG, et al
    Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged >/= 69 referred to colposcopy due to an HPV-positive screening test.
    BMC Cancer. 2023;23:405.
    >> Share

    April 2023
  55. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
    Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
    BMC Cancer. 2023;23:385.
    >> Share

  56. GAN Q, Huang X, Zhao W, Liu H, et al
    AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
    BMC Cancer. 2023;23:364.
    >> Share

  57. RAHIMI M, Akbari A, Asadi F, Emami H, et al
    Cervical cancer survival prediction by machine learning algorithms: a systematic review.
    BMC Cancer. 2023;23:341.
    >> Share

    March 2023
  58. ZHANG H, Wang X, Li Y, Bai Y, et al
    The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.
    BMC Cancer. 2023;23:222.
    >> Share

    February 2023
  59. QIN D, Bai A, Xue P, Seery S, et al
    Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology.
    BMC Cancer. 2023;23:187.
    >> Share

  60. SHI L, Yang X, He L, Zheng C, et al
    Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens.
    BMC Cancer. 2023;23:168.
    >> Share

  61. XUE P, Seery S, Wang S, Jiang Y, et al
    Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China.
    BMC Cancer. 2023;23:163.
    >> Share

    January 2023
  62. LONG H, Li Y, Wang H, Guo B, et al
    C/EBPbeta expression decreases in cervical cancer and leads to tumorigenesis.
    BMC Cancer. 2023;23:79.
    >> Share

  63. LI J, Li Y, Wang H, Shen L, et al
    Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
    BMC Cancer. 2023;23:51.
    >> Share

    December 2022
  64. ZHANG GY, Zhang R, Bai P, Li SM, et al
    Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    BMC Cancer. 2022;22:1331.
    >> Share

  65. ASSEFA T, Arefaynie M, Mebratu W, Mohammed A, et al
    Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town, Northeast Ethiopia.
    BMC Cancer. 2022;22:1330.
    >> Share

  66. KUGUYO O, Chambwe N, Nhachi CFB, Tsikai N, et al
    A cervical cancer biorepository for pharmacogenomics research in Zimbabwe.
    BMC Cancer. 2022;22:1320.
    >> Share

  67. SIRAIT LMF, Hamajima N, Suzuki Y, Wahyuningsih ES, et al
    Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: a cross-sectional study.
    BMC Cancer. 2022;22:1309.
    >> Share

  68. TERASHIMA T, Konishi H, Sato Y, Igarashi M, et al
    Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study.
    BMC Cancer. 2022;22:1303.
    >> Share

  69. OSMANI V, Fett S, Tauscher M, Donnachie E, et al
    HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    BMC Cancer. 2022;22:1293.
    >> Share

  70. JING H, Xiuhong W, Ying Y, Xiyun C, et al
    Complications of radical hysterectomy with pelvic lymph node dissection for cervical cancer: a 10-year single-centre clinical observational study.
    BMC Cancer. 2022;22:1286.
    >> Share

  71. SEN S, Khan PK, Wadasadawala T, Mohanty SK, et al
    Socio-economic and regional variation in breast and cervical cancer screening among Indian women of reproductive age: a study from National Family Health Survey, 2019-21.
    BMC Cancer. 2022;22:1279.
    >> Share

  72. HU Y, Han Y, Shen Y, Chen J, et al
    Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
    BMC Cancer. 2022;22:1270.
    >> Share

    November 2022
  73. SEYRAFI N, Homayuni A, Hosseini Z, Aghamolaei T, et al
    Effectiveness of educational intervention on women's participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model.
    BMC Cancer. 2022;22:1226.
    >> Share

  74. TAKAMIZAWA S, Yazaki S, Kojima Y, Yoshida H, et al
    High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.
    BMC Cancer. 2022;22:1215.
    >> Share

  75. LI Y, Jia M, Cao L, Yu J, et al
    Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
    BMC Cancer. 2022;22:1172.
    >> Share

  76. QIN X, Wang C, Gong G, Wang L, et al
    Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer.
    BMC Cancer. 2022;22:1149.
    >> Share

  77. DU Y, Geng G, Zhao C, Gao T, et al
    LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis.
    BMC Cancer. 2022;22:1145.
    >> Share

    October 2022
  78. MPACHIKA-MFIPA F, Kululanga LI, Kazembe A, Mfipa D, et al
    Socio-demographic determinants of cervical cancer screening uptake among women of child-bearing age in Mangochi, Malawi: a facility-based cross-sectional study.
    BMC Cancer. 2022;22:1096.
    >> Share

  79. VIKRAMDEO KS, Anand S, Pierce JY, Singh AP, et al
    Distribution of microbiota in cervical preneoplasia of racially disparate populations.
    BMC Cancer. 2022;22:1074.
    >> Share

  80. BRUNO MT, Cassaro N, Mazza G, Guaita A, et al
    Spontaneous regression of cervical intraepithelial neoplasia 3 in women with a biopsy-cone interval of greater than 11 weeks.
    BMC Cancer. 2022;22:1072.
    >> Share

  81. ZHANG J, Dong D, Wei Q, Ren L, et al
    CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
    BMC Cancer. 2022;22:1052.
    >> Share

  82. CHEN H, Gu L, Zhang M, Chen H, et al
    Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells.
    BMC Cancer. 2022;22:1039.
    >> Share

    September 2022
  83. KARPINETS TV, Wu X, Solley T, El Alam MB, et al
    Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.
    BMC Cancer. 2022;22:945.
    >> Share

    August 2022
  84. DORJI N, Tshering S, Choden S, Chhetri M, et al
    Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+).
    BMC Cancer. 2022;22:930.
    >> Share

  85. GLASMEYER L, Mcharo RD, Torres L, Lennemann T, et al
    Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    BMC Cancer. 2022;22:892.
    >> Share

  86. LI M, Xiao Y, Liu M, Ning Q, et al
    MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell.
    BMC Cancer. 2022;22:876.
    >> Share

  87. NASCIMENTO NPG, Gally TB, Borges GF, Campos LCG, et al
    Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
    BMC Cancer. 2022;22:862.
    >> Share

  88. TIITI TA, Selabe SG, Bogers J, Lebelo RL, et al
    High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
    BMC Cancer. 2022;22:854.
    >> Share

    July 2022
  89. MARTINEZ A, Chantalat E, Angeles MA, Ferron G, et al
    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
    BMC Cancer. 2022;22:810.
    >> Share

  90. CHEN J, Li C, Cao Y, Zhu L, et al
    Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
    BMC Cancer. 2022;22:793.
    >> Share

  91. HE Z, Chen R, Hu S, Zhang Y, et al
    The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
    BMC Cancer. 2022;22:776.
    >> Share

  92. SINGH G, Sharma SK, Singh SK
    miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
    BMC Cancer. 2022;22:777.
    >> Share

    June 2022
  93. MAN X, Yang X, Wei Z, Tan Y, et al
    High expression level of CXCL1/GROalpha is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.
    BMC Cancer. 2022;22:712.
    >> Share

  94. PAN B, Wan T, Jiang Y, Zheng X, et al
    Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer.
    BMC Cancer. 2022;22:655.
    >> Share

  95. ZHANG W, Cao H, Yang J, Zhao J, et al
    The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
    BMC Cancer. 2022;22:636.
    >> Share

  96. HWANG WY, Chang SJ, Kim HS, Kim NK, et al
    Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators
    BMC Cancer. 2022;22:603.
    >> Share

    May 2022
  97. CAO HZ, Yang WT, Zheng PS
    Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    BMC Cancer. 2022;22:521.
    >> Share

  98. JUDAH G, Dilib F, Darzi A, Huf S, et al
    A population survey on beliefs around cervical cancer screening: determining the barriers and facilitators associated with attendance.
    BMC Cancer. 2022;22:522.
    >> Share

  99. CHEN R, Gan Q, Zhao S, Zhang D, et al
    DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
    BMC Cancer. 2022;22:488.
    >> Share

  100. BENIDER A, Bendahhou K, Sauvaget C, Mrabti H, et al
    Evolution of patterns of care for women with cervical cancer in Morocco over a decade.
    BMC Cancer. 2022;22:479.
    >> Share

    April 2022
  101. HEMMINKI K, Kanerva A, Forsti A, Hemminki A, et al
    Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
    BMC Cancer. 2022;22:456.
    >> Share

  102. LI K, Xu H, Wang S, Qin P, et al
    Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.
    BMC Cancer. 2022;22:419.
    >> Share

  103. HE Y, Han SB, Liu Y, Zhang JJ, et al
    Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
    BMC Cancer. 2022;22:411.
    >> Share

  104. GALLARDO-ALVARADO L, Cantu-de Leon D, Ramirez-Morales R, Santiago-Concha G, et al
    Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study.
    BMC Cancer. 2022;22:401.
    >> Share

  105. WEI B, Zhang B, Xue P, Seery S, et al
    Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China.
    BMC Cancer. 2022;22:388.
    >> Share

  106. WU X, Feng H, Gao S, Feng H, et al
    A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.
    BMC Cancer. 2022;22:384.
    >> Share

  107. HOLMQVIST A, Lindahl G, Mikivier R, Uppungunduri S, et al
    Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients.
    BMC Cancer. 2022;22:371.
    >> Share

  108. CHEN L, Qing J, Xiao Y, Huang X, et al
    TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
    BMC Cancer. 2022;22:370.
    >> Share

  109. WANG H, Jiang Y, Liang Y, Wei L, et al
    Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2022;22:362.
    >> Share

    March 2022
  110. PARK SJ, Kong TW, Kim T, Lee M, et al
    Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial prot
    BMC Cancer. 2022;22:331.
    >> Share

  111. MKUU RS, Staras SA, Szurek SM, D'Ingeo D, et al
    Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study.
    BMC Cancer. 2022;22:252.
    >> Share

    February 2022
  112. ZHANG H, Yu R, Zhang L, Wang R, et al
    Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
    BMC Cancer. 2022;22:202.
    >> Share

  113. LIU W, Jiang Q, Sun C, Liu S, et al
    Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
    BMC Cancer. 2022;22:192.
    >> Share

  114. BHAT A, Yadav J, Thakur K, Aggarwal N, et al
    Transcriptome analysis of cervical cancer exosomes and detection of HPVE6*I transcripts in exosomal RNA.
    BMC Cancer. 2022;22:164.
    >> Share

  115. SINGH M, Jha RP, Shri N, Bhattacharyya K, et al
    Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study.
    BMC Cancer. 2022;22:149.
    >> Share

  116. FISCHER S, Kuebler U, Abbruzzese E, Breymann C, et al
    Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence.
    BMC Cancer. 2022;22:145.
    >> Share

  117. METAXAS T, Kenfack B, Sormani J, Tincho E, et al
    Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
    BMC Cancer. 2022;22:132.
    >> Share

    January 2022
  118. REN J, Li L, Yu B, Xu E, et al
    Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer.
    BMC Cancer. 2022;22:88.
    >> Share

  119. HOU M, Song K, Ren J, Wang K, et al
    Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.
    BMC Cancer. 2022;22:87.
    >> Share

  120. SONG F, Yan P, Huang X, Wang C, et al
    Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    BMC Cancer. 2022;22:42.
    >> Share

  121. JIANG AG, Cai X
    Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    BMC Cancer. 2022;22:4.
    >> Share

    November 2021
  122. DENG Q, Long Q, Liu Y, Yang Z, et al
    Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
    BMC Cancer. 2021;21:1282.
    >> Share

  123. KIM SI, Kim JY, Wee CW, Lee M, et al
    Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
    BMC Cancer. 2021;21:1260.
    >> Share

  124. CHEN L, Lin L, Li L, Xie Z, et al
    Lymphatic leakage after pelvic lymphadenectomy for cervical cancer: a retrospective case-control study.
    BMC Cancer. 2021;21:1242.
    >> Share

  125. YANG P, Ruan Y, Yan Z, Gao Y, et al
    Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    BMC Cancer. 2021;21:1230.
    >> Share

    October 2021
  126. ZHAO M, Pu X, Yan YJ, Zhang S, et al
    The quality of life in women with cervical cancer and precancerous lesions of Han and ethnic minorities in Southwest China.
    BMC Cancer. 2021;21:1110.
    >> Share

  127. DERESSA BT, Assefa M, Tafesse E, Kantelhardt EJ, et al
    Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia.
    BMC Cancer. 2021;21:1102.
    >> Share

  128. CHEN L, Niu Y, Wan X, Yu L, et al
    Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
    BMC Cancer. 2021;21:1095.
    >> Share

  129. CHEN C, Duan H, Zhang W, Zhao H, et al
    Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016.
    BMC Cancer. 2021;21:1091.
    >> Share

  130. SIMSONE Z, Freivalds T, Bema D, Mikelsone I, et al
    Cancer microcell initiation and determination.
    BMC Cancer. 2021;21:1087.
    >> Share

  131. CHENG J, Liu B, Wang B, Long X, et al
    Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
    BMC Cancer. 2021;21:1078.
    >> Share

    September 2021
  132. COQUAN E, Brachet PE, Licaj I, Leconte A, et al
    CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
    BMC Cancer. 2021;21:1054.
    >> Share

  133. KAWAMURA M, Koide Y, Murai T, Ishihara S, et al
    The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    BMC Cancer. 2021;21:1046.
    >> Share

  134. DESTAW A, Midaksa M, Addissie A, Kantelhardt EJ, et al
    Cervical cancer screening "see and treat approach": real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia.
    BMC Cancer. 2021;21:1031.
    >> Share

  135. YANG J, Yan Z, Wang Y, Xu J, et al
    Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
    BMC Cancer. 2021;21:997.
    >> Share

    August 2021
  136. LIU J, Liu X, Guo Z, Lv X, et al
    Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making.
    BMC Cancer. 2021;21:964.
    >> Share

  137. BONI SP, Gnahatin F, Comoe JC, Tchounga B, et al
    Barriers and facilitators in cervical cancer screening uptake in Abidjan, Cote d'Ivoire in 2018: a cross-sectional study.
    BMC Cancer. 2021;21:952.
    >> Share

  138. ZHONG G, Wang Y, Xie Q, Lin R, et al
    HPV-specific risk assessment of cervical cytological abnormalities.
    BMC Cancer. 2021;21:949.
    >> Share

  139. HANSEN BT, Campbell S, Nygard M
    Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study.
    BMC Cancer. 2021;21:935.
    >> Share

  140. WU B, Xi S
    Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    BMC Cancer. 2021;21:928.
    >> Share

    July 2021
  141. KIM JY, Lee DW, Kim MJ, Shin JE, et al
    Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018).
    BMC Cancer. 2021;21:880.
    >> Share

  142. LI X, Xu C, Yu Y, Guo Y, et al
    Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
    BMC Cancer. 2021;21:866.
    >> Share

  143. QI J, Zhou L, Li D, Yang J, et al
    Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A.
    BMC Cancer. 2021;21:819.
    >> Share

  144. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:811.
    >> Share

  145. LI Y, Luo H, Zhang X, Chang J, et al
    Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions.
    BMC Cancer. 2021;21:804.
    >> Share

  146. DAI MZ, Qiu Y, Di XH, Shi WW, et al
    Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China.
    BMC Cancer. 2021;21:769.
    >> Share

    June 2021
  147. WU B, Xi S
    Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    BMC Cancer. 2021;21:733.
    >> Share

  148. JIANG P, Cao Y, Gao F, Sun W, et al
    SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
    BMC Cancer. 2021;21:694.
    >> Share

  149. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:682.
    >> Share

  150. ZHAO J, Cao H, Zhang W, Fan Y, et al
    SOX14 hypermethylation as a tumour biomarker in cervical cancer.
    BMC Cancer. 2021;21:675.
    >> Share

  151. RAKHSHANDA S, Dalal K, Chowdhury HA, Mayaboti CA, et al
    Assessing service availability and readiness to manage cervical cancer in Bangladesh.
    BMC Cancer. 2021;21:670.
    >> Share

  152. AKHAVAN S, Alibakhshi A, Parsapoor M, Alipour A, et al
    Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
    BMC Cancer. 2021;21:667.
    >> Share

  153. ZOU D, Guo M, Zhou Q
    A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    BMC Cancer. 2021;21:661.
    >> Share

    May 2021
  154. DENG ZM, Dai FF, Zhou Q, Cheng YX, et al
    Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis.
    BMC Cancer. 2021;21:583.
    >> Share

  155. CHEN HH, Meng WY, Li RZ, Wang QY, et al
    Potential prognostic factors in progression-free survival for patients with cervical cancer.
    BMC Cancer. 2021;21:531.
    >> Share

  156. LI W, Xiong L, Zhu Q, Lu H, et al
    Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
    BMC Cancer. 2021;21:484.
    >> Share

    April 2021
  157. FENG Y, Wang Y, Xie Y, Wu S, et al
    Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    BMC Cancer. 2021;21:450.
    >> Share

  158. LEE F, Bula A, Chapola J, Mapanje C, et al
    Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
    BMC Cancer. 2021;21:428.
    >> Share

  159. LI Y, Chen Z, Wang X, Li X, et al
    Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.
    BMC Cancer. 2021;21:442.
    >> Share

  160. LIU H, Ye X, Li D, Yao Q, et al
    Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study.
    BMC Cancer. 2021;21:421.
    >> Share

  161. MA D, Pan Z, Chang Q, Zhang JJ, et al
    KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
    BMC Cancer. 2021;21:377.
    >> Share

  162. TISLER A, Ojavee SE, Veerus P, Soodla P, et al
    Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
    BMC Cancer. 2021;21:350.
    >> Share

    March 2021
  163. ZHANG SW, Luo RZ, Sun XY, Yang X, et al
    Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
    BMC Cancer. 2021;21:332.
    >> Share

  164. SHARMIN S, Zohura FT, Islam MS, Shimonty A, et al
    Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    BMC Cancer. 2021;21:289.
    >> Share

  165. GAETE S, Auguste A, Bhakkan B, Peruvien J, et al
    Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
    BMC Cancer. 2021;21:281.
    >> Share

  166. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
    Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    BMC Cancer. 2021;21:264.
    >> Share

  167. JU Z, Guo W, Gu S, Zhou J, et al
    CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy.
    BMC Cancer. 2021;21:243.
    >> Share

  168. ARARSA T, Tadele N, Ayalew Y, Gela D, et al
    Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey.
    BMC Cancer. 2021;21:224.
    >> Share

    February 2021
  169. YANG E, Huang S, Ran X, Huang Y, et al
    The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    BMC Cancer. 2021;21:203.
    >> Share

  170. CHU G, Liu X, Yu W, Chen M, et al
    Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study.
    BMC Cancer. 2021;21:133.
    >> Share

  171. GOUY S, Seebacher V, Chargari C, Terroir M, et al
    False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
    BMC Cancer. 2021;21:135.
    >> Share

  172. OBOL JH, Lin S, Obwolo MJ, Harrison R, et al
    Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
    BMC Cancer. 2021;21:110.
    >> Share

  173. CHI RA, van der Watt P, Wei W, Birrer MJ, et al
    Inhibition of Kpnbeta1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
    BMC Cancer. 2021;21:106.
    >> Share

    January 2021
  174. DEL MORAL-HERNANDEZ O, Hernandez-Sotelo D, Alarcon-Romero LDC, Mendoza-Catalan MA, et al
    TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    BMC Cancer. 2021;21:39.
    >> Share

    December 2020
  175. BAO H, Wang L, Brown M, Zhang M, et al
    A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities.
    BMC Cancer. 2020;20:1191.
    >> Share

    November 2020
  176. TAKEKUMA M, Takahashi F, Mabuchi S, Kudaka W, et al
    Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.
    BMC Cancer. 2020;20:1169.
    >> Share

  177. CAI L, Hu C, Yu S, Liu L, et al
    Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.
    BMC Cancer. 2020;20:1133.
    >> Share

  178. PITTALIS C, Panteli E, Schouten E, Magongwa I, et al
    Breast and cervical cancer screening services in Malawi: a systematic review.
    BMC Cancer. 2020;20:1101.
    >> Share

  179. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Gil Quijano AM, Valbuena AM, et al
    Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis.
    BMC Cancer. 2020;20:1097.
    >> Share

  180. BANU N, Riera-Leal A, Haramati J, Ortiz-Lazareno PC, et al
    B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
    BMC Cancer. 2020;20:1083.
    >> Share

    October 2020
  181. LIU J, Li Y, Chen X, Xu X, et al
    Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.
    BMC Cancer. 2020;20:1029.
    >> Share

    September 2020
  182. GESINK MP, Chamberlain RM, Mwaiselage J, Kahesa C, et al
    Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
    BMC Cancer. 2020;20:939.
    >> Share

  183. CHEN M, Wang H, Liang Y, Hu M, et al
    Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2020;20:926.
    >> Share

  184. CHEN S, Li K
    HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    BMC Cancer. 2020;20:924.
    >> Share

    July 2020
  185. TESFAW G, Ahmed Y, Gedefaw L, Dube L, et al
    Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia.
    BMC Cancer. 2020;20:706.
    >> Share

  186. LEE SY, Chae DK, Lee SH, Lim Y, et al
    Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    BMC Cancer. 2020;20:694.
    >> Share

  187. AARNIO R, Ostensson E, Olovsson M, Gustavsson I, et al
    Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    BMC Cancer. 2020;20:645.
    >> Share

    June 2020
  188. KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
    Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
    BMC Cancer. 2020;20:577.
    >> Share

  189. ITO M, Kodaira T, Koide Y, Okuda T, et al
    Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    BMC Cancer. 2020;20:540.
    >> Share

  190. VAN DE LAAR RLO, Hofhuis W, Duijnhoven RG, Polinder S, et al
    Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    BMC Cancer. 2020;20:539.
    >> Share

    May 2020
  191. BRUNO MT, Scalia G, Cassaro N, Boemi S, et al
    Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
    BMC Cancer. 2020;20:444.
    >> Share

  192. ZHANG J, Zhang D, Yang Z, Wang X, et al
    The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    BMC Cancer. 2020;20:443.
    >> Share

  193. GUO HT, Bi XH, Lei T, Lv X, et al
    Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    BMC Cancer. 2020;20:441.
    >> Share

  194. CHEN P, Jiao L, Ren F, Wang DB, et al
    Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    BMC Cancer. 2020;20:423.
    >> Share

  195. EJEGOD DM, Lagheden C, Bhatia R, Pedersen H, et al
    Clinical validation of full genotyping CLART(R) HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
    BMC Cancer. 2020;20:396.
    >> Share

    April 2020
  196. SILVA NNT, Santos ACS, Nogueira VM, Carneiro CM, et al
    3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.
    BMC Cancer. 2020;20:323.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016